Relationship between responsiveness to erythropoiesis-stimulating agent and long-term outcomes in chronic hemodialysis patients: a single-center cohort study

Tetsuya Ogawa(Nihon University), Kosaku Nitta(Tokyo Women's Medical University), Masayo Sato(Tokyo Women's Medical University), Kuniaki Otsuka(University of Minnesota), Tetsuri Yamashita(Tokyo Women's Medical University Adachi Medical Center), Ai Kyono(Tokyo Women's Medical University Adachi Medical Center), Himiko Shimizu(Tokyo Women's Medical University)
International Urology and Nephrology
June 26, 2013
10.1007/s11255-013-0494-z
Cited by 25

Related Papers

An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013)
|Therapeutic Apheresis and Dialysis|2015|425
Annual dialysis data report for 2018, JSDT Renal Data Registry: survey methods, facility data, incidence, prevalence, and mortality
|Renal Replacement Therapy|2020|170
Left Ventricular Hypertrophy Is Associated with Arterial Stiffness and Vascular Calcification in Hemodialysis Patients
|Hypertension Research|2004|161
Annual dialysis data report 2017, JSDT Renal Data Registry
|Renal Replacement Therapy|2019|158
P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines
|Head & Neck|2003|153